MedPath

FUROSEMIDE INJECTION USP

FUROSEMIDE INJECTION USP

Approved
DIN Number

02384094

Drug Class

Human

Market Date

Aug 22, 2013

Company
HC

hikma canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02384094
AIG Number0101944003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C03CA01 FUROSEMIDE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous ,  Intramuscular
AHFS Classification40:28.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

FUROSEMIDEActive
Strength: 20 MG / 2 ML
Monograph: FUROSEMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.